PTSM: Pharmaceutical Technology Sourcing and Management, May 2, 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PTSM: Pharmaceutical Technology Sourcing and Management, May 2, 2012
Biologics
White House Releases National Bioeconomy Blueprint
By Patricia Van Arnum
The Obama administration details five strategic imperatives to drive bioscience research as a means of economic growth.
Contract Services
CROs Urge for Modernization of Clinical Trials
By Patricia Van Arnum
Clinical research organizations see reform in clinical-trial process, including the establishment of chief innovation officer at FDA.
Outsourcing
Ways to Recover Lost Margins
By Gregg Brandyberry
Recovery audits and other past practices in procurement can improve the bottom line.
CSR and Sustainability Forum
The Marriage of Global Health and Sustainability
By Patricia Van Arnum
Industry leaders share their perspectives on how the pharmaceutical industry is and can further advance sustainability.
GlaxoSmithKline Outlines Its Sustainability Goals
By Patricia Van Arnum
The company provides progress made in 2011 and future environmental objectives.
CSR and Sustainability in the News
A roundup of developments in corporate social responsibility and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Click here